The accompanying unaudited interim condensed consolidated financial statements have not been reviewed by the Company’s independent auditor. They have been prepared by management in accordance with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X, and, therefore, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations, cash flows, and stockholders' equity in conformity with generally accepted accounting principles. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature. Operating results for the three months ended March 31, 2020, are not necessarily indicative of the results that can be expected for the year ending December 31, 2020.

Unless the context otherwise requires, all references in this report to “Triton,” “the Company,” “we,” “us,” or “our” are to Triton Emission Solutions Inc., collectively with its subsidiary Ecolutions, Inc.

1

TRITON EMISSION SOLUTIONS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(EXPRESSED IN US DOLLARS)

(Unaudited, Prepared by Management)

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.

F-1

TRITON EMISSION SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(EXPRESSED IN US DOLLARS)

(Unaudited, Prepared by Management)

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.

F-2

TRITON EMISSION SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

(EXPRESSED IN US DOLLARS)

(Unaudited, Prepared by Management)

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.

F-3

TRITON EMISSION SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(EXPRESSED IN US DOLLARS)

(Unaudited, Prepared by Management)

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.

F-4

TRITON EMISSION SOLUTIONS INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2020

(Unaudited, Prepared by Management)

NOTE 1 - ORGANIZATION AND NATURE OF OPERATIONS

Triton Emission Solutions Inc. (the “Company”) was incorporated in the state of Delaware on March 2, 2000. On August 25, 2014, the Company changed its name from Poly Shield Technologies Inc. to Triton Emission Solutions Inc. The Company’s shares are listed on the OTCPink under the symbol “DSOX”.

The Company’s main focus is the development and marketing of its proprietary DSOX Fuel Purification (the “DSOX”) and Njord Exhaust Gas Scrubber (the “Njord”) Systems, designed to remove sulfur from marine fuel and exhaust gases. The technology is currently aimed at the maritime industry which includes vessels for cruise-line, freight shipping and tanker companies.

Basis of presentation

The unaudited interim condensed consolidated financial statements included herein have been prepared by, and are the responsibility of, the Company’s management in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Due to a weak financial condition, the Company has not been able to retain an independent auditor to perform a review of these unaudited interim consolidated financial statements. They do not include all information and notes required by generally accepted accounting principles for complete financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the notes to the unaudited consolidated financial statements included in the Annual Report on Form 10-K of the Company for the year ended December 31, 2019. In the opinion of management, all adjustments (including normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2020, are not necessarily indicative of the results that may be expected for the year ending December 31, 2020. For further information, these unaudited interim condensed consolidated financial statements and the related notes should be read in conjunction with the Company’s unaudited consolidated financial statements for the year ended December 31, 2019, included in the Company’s report on Form 10-K.

Reclassifications

Certain prior period amounts in the accompanying unaudited interim condensed consolidated financial statements have been reclassified to conform to the current period’s presentation. These reclassifications had no effect on the consolidated results of operations or financial position for any period presented.

Going concern

The accompanying unaudited, management-prepared, interim condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. Continuation as a going concern is dependent upon the ability of the Company to obtain the necessary financing to meet its obligations and pay its liabilities arising from normal business operations when they come due and ultimately upon its ability to achieve profitable operations.

As of March 31, 2020, the Company had not achieved profitable operations and had a working capital deficit of $19,247,802 and accumulated a deficit of $82,729,496. In addition, as of March 31, 2020, the Company owed a total of $12,047,322 to KF Business Ventures, LP (“KFBV”), an entity controlled by the Company’s Chairman, under the terms of three separate loan agreements with KFBV (Note 4). Should KFBV serve the Company with default notice and request a payment of the amounts owed, the Company may not be able to continue as a going concern and may be required to file for bankruptcy. The likelihood and outcome of these matters cannot be predicted with any certainty at this time and raises substantial doubt that the Company will be able to continue as a going concern.

These unaudited interim condensed consolidated financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be unable to continue as a going concern. Management intends to obtain additional funding by borrowing funds from its directors and officers, issuing promissory notes and/or a private placement of common stock.

F-5

NOTE 2 - RELATED PARTY TRANSACTIONS

As at March 31, 2020, the Company owed $205,206 (2019 - $205,336) to an entity controlled by the Chief Financial Officer (“CFO”) of the Company.

During the three-month periods ended March 31, 2020 and 2019, the Company did not have any transactions with its related parties other than the interest accrued on notes and advances payable, and borrowing funds to support the Company’s operations (Notes 3 and 4).

NOTE 3 - NOTES AND ADVANCES PAYABLE

The tables below summarize the short-term loans outstanding as at March 31, 2020 and December 31, 2019:

(1)On December 12, 2011, the Company entered into a loan agreement with a third-party creditor for a $15,000 loan in exchange for an unsecured promissory note. On February 13, 2012, the Company borrowed an additional $12,000 from the same creditor in exchange for an unsecured promissory note. The loans accrue interest at a rate of 8% and are due on demand. During the three-month period ended March 31, 2020, the Company recorded $1,024 in interest expense associated with these loans (2019 - $935). As at March 31, 2020, the Company owed $52,017 (2019 - $50,993) under these loans. 

(2)On August 14, 2012, the Company entered into a loan agreement with a third-party creditor for a $15,000 loan in exchange for an unsecured non-interest bearing promissory note payable on demand. As at March 31, 2020, and December 31, 2019 the Company continued to owe the full amount under the promissory note. 

(3)In September and October of its Fiscal 2010, the Company entered into a number of loan agreements with a third-party creditor for a total of $34,500 in exchange for unsecured promissory notes. On November 9, 2010, the Company entered into a loan agreement with another third-party creditor for a $15,000 in exchange for an unsecured promissory note. 

F-6

The above loans accrue interest at a rate of 7% and are due on demand. During the three-month period ended March 31, 2020, the Company recorded $1,652 in interest expense associated with these loans (2019 - $1,524). As at March 31, 2020, the Company owed a total of $95,748 (2019 - $94,096) to third party creditors under the 7% loans.

(4)In 2012 the Company entered into series of Loan Agreements with Quarry Bay Capital LLC for a total of CAD$190,000 (the “Quarry Bay Loan”). The Quarry Bay Loan accumulates interest at 6% per annum and is payable on demand. During the three-month period ended March 31, 2020, the Company recorded $2,661 in interest expense associated with the Quarry Bay Loan (2019 - $2,507). As at March 31, 2020, the Company owed $170,290 (2019 - $183,255) under the Quarry Bay Loan. 

(5)On July 28, 2015, and November 6, 2015, the Company entered into two separate bridge loan agreements (the “Norling Loans”) with its major shareholder and former President and CTO, Rasmus Norling. Pursuant to the Norling Loans, Mr. Norling agreed to lend to the Company total of $400,000 in exchange for unsecured promissory notes. On August 31, 2015, the Company entered into a bridge loan agreement with KFBV, whereby KFBV agreed to lend to the Company $200,000 in exchange for an unsecured promissory note (the “KFBV Bridge Loan”). 

The Norling Loans and KFBV Bridge Loan accrue interest at a rate of 6% and were due December 31, 2016. During the three-month period ended March 31, 2020, the Company recorded $7,773 in interest expense associated with the Norling Loans (2019 - $7,241) and $3,897 in interest expense associated with the KFBV Bridge Loan (2019 - $3,630). As at March 31, 2020, the Company owed $524,855 (2019 - $517,082) under the Norling Loans and $263,129 (2019 - $259,232) under the KFBV Bridge Loan.

As of March 31, 2020, the Norling Loans and KFBV Bridge Loan are in default, however, the Company has not been served with a default notice.

(6)In September 2016, the Company issued an unsecured promissory note to KFBV for gross proceeds of $110,000 (the “KFBV Note”). As part of the terms of the KFBV Note the Company agreed to grant KFBV the right to offset the cash payable by KFBV to exercise the warrants to purchase shares of the Company’s common stock against the corresponding amount the Company would have to pay for outstanding indebtedness under this KFBV Note. 

The KFBV Note had an interest rate of 10% and was due January 15, 2017. Under the terms of the KFBV Note, in the event of default the interest rate increases to 15% per annum until such time that the default is cured. During the three-month period ended March 31, 2020, the Company recorded $4,114 in interest expense associated with the KFBV Note (2019 - $4,068). As at March 31, 2020, the Company owed $166,499 (2019 - $162,385) under the KFBV Note.

As of March 31, 2020, the KFBV Note is in default, however, the Company has not been served with a default notice.

(7)During the three-month period ended March 31, 2020, KFBV advanced the Company an additional $612 (2019 - $9,392) for working capital, bringing the total cash advanced for working capital to $370,730 (2019 - $370,118). The working capital advances are unsecured, due on demand and accumulate interest at a rate of 10% per annum compounded monthly. During the three-month period ended March 31, 2020, the Company recorded $11,879 in interest expense associated with these advances (2019 - $10,166). As at March 31, 2020, the Company owed $485,002 (2019 - $472,511) on account of working capital advances it borrowed from KFBV. 

F-7

NOTE 4 - KFBV LOANS AND DERIVATIVE LIABILITY

The tables below summarize the details of the loans payable to KFBV under three separate loan agreements the Company entered into with KFBV during its fiscal 2014 and 2015:

First KF Loan Payable

At March 31, 2020, the Company owed KFBV a total of $4,390,338 under a loan agreement dated for reference February 11, 2014, as amended on March 10, 2014, September 8, 2014, and on December 17, 2015 (the “First KF Loan”). The principal under the First KF Loan accumulated interest at 10% per annum compounded monthly. The Company did not repay the First KF Loan on January 15, 2017, its amended maturity date, therefore as of January 15, 2017, the interest rate increased to 15%, the default rate  of interest, and the Company recorded a penalty of $131,978, representing 5% of the full balance due under the First KF Loan on its maturity.

During the three months ended March 31, 2020, the Company recorded $155,361 (2019 - $132,355) in interest expense on the First KF Loan.

In consideration for the First KF Loan, as amended, the Company issued to KFBV non-transferrable share purchase warrants to purchase an aggregate of 10,448,878 shares of its common stock at an exercise price of $0.10 per share, as amended. Warrants for 9,254,546 expire on January 15, 2021, and warrants for 1,194,332 shares expire on September 1, 2021 (the “First KF Warrants”). The First KF Warrants include a down-round provision whereby the exercise price of the First KF Warrants could be adjusted to the lowest offering price of any options, warrants or shares issued subsequent to the issuance of the First KF Warrants; in case of the Company defaulting on repayment of the First KF Loan, the First KF Warrants can be exercised at a 50% discount to volume weighted average price of the common stock of the Company over the five trading days preceding the date of exercise.

The First KF Warrants were determined to be a derivative under ASC 815. At March 31, 2020, the fair value of the derivative liability associated with the First KF Warrants was $10,449 (December 31, 2019 - $11,643), and was determined using the Binomial Lattice model using the following assumptions:

F-8

Second KF Loan Payable

At March 31, 2020, the Company owed KFBV a total of $4,915,939 under a loan agreement dated for reference July 28, 2014, as amended on December 17, 2015 (the “Second KF Loan”). The principal under the Second KF Loan accumulated interest at 10% per annum compounded monthly. The Company did not repay the Second KF Loan on January 15, 2017, its amended maturity date, therefore as of January 15, 2017, the interest rate increased to 15%, the default rate  of interest, and the Company recorded a penalty of $147,779, representing 5% of the full balance due under the Second KF Loan on its maturity.

During the three months ended March 31, 2020, the Company recorded $173,960 (2019 - $148,200) in interest expense on the Second KF Loan at 15% per annum, the default rate of interest.

In consideration for the Second KF Loan, as amended, the Company issued to KFBV non-transferrable share purchase warrants to purchase an aggregate of 10,937,320 shares of its common stock at an exercise price of $0.10 per share, as amended. Warrants for 9,600,000 expire on January 15, 2021, and warrants for 1,337,320 shares expire on September 1, 2021 (the “Second KF Warrants”). The Second KF Warrants include a down-round provision whereby the exercise price of the Second KF Warrants could be adjusted to the lowest offering price of any options, warrants or shares issued subsequent to the issuance of the Second KF Warrants; in case of the Company defaulting on repayment of the  Second KF Loan, the Second KF Warrants can be exercised at a 50% discount to volume weighted average price of the common stock of the Company over the five trading days preceding the date of exercise.

The Second KF Warrants were determined to be a derivative under ASC 815. At March 31, 2020, the fair value of the derivative liability associated with the Second KF Warrants was $10,938 (December 31, 2019 - $12,275), and was determined using the Binomial Lattice model using the following assumptions:

Third KF Loan Payable

At March 31, 2020, the Company owed KFBV a total of $2,741,045 under a loan agreement dated for reference January 8, 2016 (the “Third KF Loan”). The principal under the Third KF Loan accumulated interest at 10% per annum compounded monthly. The Company did not repay the Third KF Loan on January 15, 2017, its maturity date, therefore as of January 15, 2017, the interest rate increased to 15%, the default rate  of interest, and the Company recorded a penalty of $82,399, representing 5% of the full balance due under the Third KF Loan on its maturity. The Third KF Loan may be converted into shares of the Company’s common stock at a conversion price of $0.10 per share (the “Third KF Loan Conversion Feature”). In case of default, the conversion price is calculated based on a 50% discount to the volume weighted average price of the Company’s stock over the last five days of trading immediately preceding the date of exercise.

During the three months ended March 31, 2020, the Company recorded $96,997 (2019 - $82,634) in interest expense on the Third KF Loan at 15% per annum, the default rate of interest.

In consideration for the Third KF Loan Agreement, the Company issued to KFBV non-transferrable share purchase warrants for a total of 8,000,000 shares of the Company’s common stock, exercisable at a price of $0.10 per share for a period expiring January 15, 2021 (the “Third KF Warrants”). The Third KF Warrants include a down-round provision whereby the exercise price of the Third KF Warrants could be adjusted to the lowest offering price of any options, warrants or shares issued subsequent to the issuance of the Third KF Warrants; in case of the Company defaulting on repayment of the  Third KF Loan, the Third KF Warrants can be exercised at a 50% discount to volume weighted average price of the common stock of the Company over the five trading days preceding the date of exercise.

F-9

The Third KF Warrants and the Third KF Loan Conversion Feature were determined to be derivatives under ASC 815. At March 31, 2020, the fair value of the derivative liability associated with the Third KF Warrants was $8,000 (2019 - $8,000), and was determined using the Binomial Lattice model using the following assumptions:

The fair value of the Third KF Loan Conversion Feature was determined using the Binomial Lattice model using the following assumptions:

The decrease in shares price may result in the Company having to issue up to 2,532,044,575 shares of its common stock should KFBV decide to exercise its conversion rights under the Third KF Loan.

Summary of the Derivative Liability - Conversion Feature

A summary of the derivative liability associated with the Conversion Feature under the Third KF Loan Agreement is as follows:

F-10

Summary of the Derivative Liabilities - Warrants

A summary of the derivative liabilities associated with the warrants under the KF Loan Agreements and their amendments is as follows:

NOTE 5 - SHARE CAPITAL

During the three months ended March 31, 2020, the Company did not have any transactions that resulted in issuance of its common stock.

Warrants

At March 31, 2020 and December 31, 2019, the Company had 29,386,198 warrants issued and exercisable as follows:

At March 31, 2020, the weighted-average remaining contractual life of the outstanding share purchase warrants was 0.85 years.

Options

Effective September 8, 2014, the Company adopted the 2014 Stock Option Plan (the "2014 Plan"). The 2014 Plan allows the Company to grant awards to its officers, directors, and employees.  In addition, the Company may grant awards to individuals who act as consultants to the Company, so long as those consultants do not provide services connected to the offer or sale of the Company’s securities in capital raising transactions and do not directly or indirectly promote or maintain a market for the Company’s securities.

The Company reserved a total of 13,200,000 shares of its common stock for issuance under the 2014 Plan. However, under the terms of the 2014 Plan, at any time after January 1, 2015, the Company can increase the number of authorized shares available under the 2014 Plan up to 15% of the total number of shares of common stock then outstanding.

F-11

A continuity schedule of options is as follows:

At March 31, 2020, the remaining contractual life of the outstanding options to purchase the shares of the Company’s common stock was 1.94 years.

On September 8, 2014, the Company granted options to acquire up to 2,500,000 shares of the Company’s common stock to a Director (the “Options”). These Options were issued under the 2014 Plan.  The Options vested at a rate of 500,000 shares per year, beginning September 1, 2014, and had initial exercise price of $0.50 per share. The Options expire five years after the vesting date thereof. On December 17, 2015, the Options were repriced to $0.10 in accordance with the provisions under the Stock Option Agreement with the Director. As at March 31, 2020, 500,000 options expired unexercised.

F-12

Cautionary Statement Regarding Forward-Looking Statements

The information in this Quarterly Report contains forward-looking statements. These forward-looking statements involve risks and uncertainties, including statements regarding Triton’s capital needs, business strategy and expectations. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential” or “continue”, the negative of such terms or other comparable terminology. Actual events or results may differ materially. In evaluating these statements, you should consider various factors, including the risks outlined from time to time, in other reports Triton files with the Securities and Exchange Commission.

The forward-looking statements in this Quarterly Report on Form 10-Q for the interim period ended  March 31, 2020, are subject to risks and uncertainties that could cause actual results to differ materially from the results expressed in or implied by the statements contained in this report. As a result, the identification and interpretation of data and other information and their use in developing and selecting assumptions from and among reasonable alternatives requires the exercise of judgment. To the extent that the assumed events do not occur, the outcome may vary substantially from anticipated or projected results, and accordingly, no opinion is expressed on the achievability of those forward-looking statements. No assurance can be given that any of the assumptions relating to the forward-looking statements specified in the following information are accurate.

All forward-looking statements are made as of the date of the filing of this Quarterly Report on Form 10-Q and Triton disclaims any obligation to publicly update these statements or disclose any difference between its actual results and those reflected in these statements. Triton may, from time to time, make oral forward-looking statements. Triton strongly advises that the above paragraphs and the risk factors described in this Quarterly Report and in Triton’s other documents filed with the United States Securities and Exchange Commission should be read for a description of certain factors that could cause the actual results of Triton to materially differ from those in the oral forward-looking statements. Triton disclaims any intention or obligation to update or revise any oral or written forward-looking statements whether as a result of new information, future events or otherwise.

Cautionary Statement of No Auditor Review

The unaudited interim condensed consolidated financial statements included in this quarterly report on Form 10-Q have not been reviewed by an independent auditor. They have been prepared by management of the Company in accordance with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X, and, therefore, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations, cash flows, and stockholders' equity in conformity with generally accepted accounting principles. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature.

The discussion provided in this Quarterly Report should be read in conjunction with our Annual Report on Form 10-K along with unaudited, management prepared, consolidated financial statements for the year ended December 31, 2019, filed with the United States Securities and Exchange Commission (the “SEC”) on March 30, 2020.

OVERVIEW

We were incorporated under the laws of the State of Delaware on March 2, 2000. We are in the business of developing and marketing emission abatement technologies for the marine industry worldwide.

Our main products are represented by the Njord Exhaust Gas Scrubber System (the “Njord System”) and the DSOX Fuel Purification System (the “DSOX-20” or “DSOX System”). The main purpose of the Njord System is to clean the exhaust gases from excess sulfur following the internal combustion process within a ships’ engine, whereas the DSOX-20 is a pre-combustion de-sulfurization technology designed to remove alkali metals, such as sulfur and sodium, from heavy marine fuel.

2

Both systems can work as stand-alone units and can be used in conjunction with one another to get the ultimate results. The fairly small size of Njord System and capability of it working in both open and closed loop modes makes the system versatile for installation on new builds as well as for retrofitting existing vessels. Its unique design does not require the addition of any chemicals and results in minimal back pressure, allowing for an extended longevity of a ships’ engine.

On April 6, 2020, we received a notice from Dale Matheson Carr-Hilton Labonte LLP (“DMCL”), our independent auditor, regarding their resignation, which was made effective April 6, 2020. Based on the confirmation from DMCL, no reportable event has arisen during the term of their engagement.

RESULTS OF OPERATIONS

Three Months Summary

Revenues

We did not generate any revenue during the three months ended March 31, 2020 and 2019. Due to significant shortage of financial resources, we do not expect to have operating revenue in the foreseeable future.

Operating Expenses

During the three-month period ended March 31, 2020, our operating expenses decreased by $10,978 or 60.7% to $7,122 as compared to $18,100 we incurred during the three-month period ended March 31, 2019. The largest expense items during the current period included professional fees of $3,123 (2019 - $14,314), which were mainly associated with maintenance of our patents and patent applications, and filing and regulatory fees of $3,238 (2019 - $2,308).

Other Items

During the three months ended March 31, 2020, we recorded $699,764 loss (2019 - $437,258) on cumulative change in the fair value of the derivative liabilities associated with the warrants we issued to KFBV pursuant to the KF Loans and the conversion feature available under the Third KF Loan. The cumulative change in fair value of the derivative liabilities consisted of $2,531 gain (2019 - $18,854 loss) we recorded on the fair values of the derivative liabilities associated with the KF Warrants and $702,295 loss (2019 - $418,404) we recorded on fair values of the derivative liability associated with the conversion feature available under the Third KF Loan Agreement.

During the three months ended March 31, 2020, we recorded a total of $459,318 in interest expenses (2019 - $393,108), of which $426,318 was associated with interest accrued on KF Loans (2019 - $363,189) and $33,000 was associated with interest accrued on the notes payable we issued to Mr. Norling, KFBV, and other third-party lenders (2019 - $29,919).

During the three months ended March 31, 2020 we recorded an unrealized gain on foreign exchange, which amounted to $16,813 (2019 - loss of $3,769).

3

Liquidity and Capital Resources

Our financial position at March 31, 2020 and December 31, 2019 was as follows:

As of March 31, 2020, we had a cash balance of $2,389, a working capital deficit of $19,247,802, and cash flows used in operations of $61 for the three months then ended. Of our working capital deficit at March 31, 2020, $29,387 was attributed to the fair value of the derivative liabilities associated with the KF Warrants and $2,532,045 was attributed to the Third KF Loan Conversion Feature. During the three-month period ended March 31, 2020, we funded our operations with $612 we received from KFBV under the advances for working capital which accumulate interest at 10% per annum compounded monthly.

As of March 31, 2020, we owed a total of $12,047,322 (2019 - $11,621,004) to KFBV under the terms of the First KF Loan, the Second KF Loan and the Third KF Loan, consisting of (i) $5,900,000 (2019 - $5,900,000) in principal amount of all KF Loans, (ii) $1,343,113 (2019 - $1,343,113) in accrued interest thereon calculated using the stated interest rate of 10% per annum compounded monthly until January 15, 2017, when all  KF Loans became due and payable, (iii) $4,442,053 (2019 - $4,015,735) in accrued interest at a default rate of interest, which was calculated on $7,243,113 owed and payable on January 15, 2017, and (iv) $362,156 (2019 - $362,156) associated with penalty we accrued on an unpaid balance due on January 15, 2017.

During the three-month period ended March 31, 2020, our operating activities were not generating any cash flows. Our only source of financing during the three-month period ended March 31, 2020, came from KFBV advances for working capital. The amount of cash that we have generated from our operations to date is significantly less than our current debt obligations, including our debt obligations under the KF Loans, which became due and payable on January 15, 2017, and as of the date of the filing of this Form 10-Q are in default.

There is no assurance that we will be able to generate sufficient cash from our operations to repay the amounts owing under the KF Loans should KFBV furnish us with a demand to pay, or to service our other debt obligations.  If we are unable to generate sufficient cash flow from our operations to repay the amounts owing when due, we may be required to raise additional financing, or re-negotiate the terms of our debt obligations. Our ability to raise financing from other sources is restricted under the terms of the KF Loan Agreements. Under the terms of those agreements, we may not incur additional debt financing (other than trade payables incurred in the ordinary course of business), sell any material assets, sell any of our equity securities as part of any transaction that would result in a change in control, or engage in any corporate reorganization while any amounts remain outstanding under KF Loan agreements without KFBV’s prior written consent.

Although Robert C. Kopple, the Chairman of our Board of Directors, is the principal of KFBV, there is no assurance that we will be able to obtain additional financing from KFBV, re-negotiate the terms of the KF Loans, or obtain KFBV’s consent to other financing alternatives, if needed.

Cash Flows

Net Cash Used in Operating Activities

Net cash used in operating activities during the three-month period ended March 31, 2020, was $61. This cash was primarily used to cover our cash operating expenses of $7,112 and was offset by a $4,146 decrease in our prepaid expenses, and a $2,905 increase in our accounts payable and accrued liabilities.

4

Non-cash Items

During the three months ended March 31, 2020 and 2019, our net loss was further increased by the following expenses that did not have any impact on cash used in operations:

·$459,318 (2019 - $393,108) in interest we accrued on our notes and advances payable, of which $426,318 (2019 - $363,189) was associated with interest we accrued on the balances payable on the KF Loans; 

·$699,764 loss (2019 - $437,258) we recorded on revaluation of the derivative liabilities associated with the KF Warrants and the Third KF Loan Conversion Feature as, pursuant to the guidance provided by ASC 815, we must revalue derivative liability at each reporting period based on the fair market value of our common shares on the reporting date. 

·$16,803 gain (2019 - $3,801 loss) we recorded on changes associated with foreign exchange fluctuations. 

Net Cash Provided by Financing Activities

During the three-month period ended March 31, 2020, KFBV advanced to us $612 (2019 - $9,392) for working capital. These advances accumulate interest at 10% per annum and are payable on demand.

As of March 31, 2020, we owed a total of $12,047,322 under the KF Loans, consisting of (i) $5,900,000 in principal amount of all KF Loans, (ii) $1,343,113 in accrued interest thereon calculated using the stated interest rate of 10% per annum, (iii) $4,442,053 in accrued interest at a default rate of interest, and (iv) $362,156 associated with late payment fee we accrued on an unpaid balance due on January 15, 2017. At March 31, 2020, the KF Loans were in default; however, we have not been served with a default notice by KFBV.

Going Concern

The notes to our condensed consolidated financial statements at March 31, 2020, disclose our uncertain ability to continue as a going concern. As of the date of this Quarterly report on Form 10-Q we have accumulated a deficit of $82,729,496 and additional financing will be required to fund and support our operations.

In February of 2017, majority of our top management resigned from their positions with the Company. Resignations of Mr. Aasen and Mr. Norling have left the Company without technical expertise required for the Company to continue development and marketing of our emission technologies, creating an uncertainty as to our ability to finalize our current projects to install our DSOX Fuel Purification Systems. In April 2017 we commissioned Norling Inc. to perform the testing of our DSOX Fuel Purification Systems, which were completed in late June 2017, however, did not yield satisfactory results required to secure potential contracts on installation.

The results of the tests confirmed that more research and further improvements to our emission abatement systems will be required in order to achieve industry-specific requirements. Should we decide to continue our operations and further development of our DSOX and NJORD Systems, we will be required to retain several engineers with relevant experience in the emission abatement technologies to work on the above projects.  In order to be able to retain new staff or consultants we will be required to raise additional debt or equity financing, which may become challenging based on the current debt covenants under our existing KFBV Loan Agreements, and our share structure.

On April 6, 2020, our independent auditor resigned. Based on the confirmation from DMCL, no reportable event has arisen during the term of their engagement, however, we do not have sufficient funds to continue to retain their services.

The financial statements do not include any adjustments that might result from the outcome of these uncertainties.

5

Uncertainty due to Global Outbreak of COVID-19

In March of 2020, the World Health Organization declared an outbreak of COVID-19 Global pandemic. The COVID-19 has impacted vast array of businesses through the restrictions put in place by most governments internationally, including the USA federal government as well as provincial and municipal governments, regarding travel, business operations and isolation/quarantine orders. At this time, it is unknown to what extent the impact of the COVID-19 outbreak may have on the Company as this will depend on future developments that are highly uncertain and that cannot be predicted with confidence. These uncertainties arise from the inability to predict the ultimate geographic spread of the disease, and the duration of the outbreak, including the duration of travel restrictions, business closures or disruptions, and quarantine/isolation measures that are currently, or may be put, in place world-wide to fight the virus. While the extent of the impact is unknown, the COVID-19 outbreak may hinder the Company’s ability to raise financing for operating costs due to uncertain capital markets, supply chain disruptions, increased government regulations and other unanticipated factors, all of which may also negatively impact the Company’s business and financial condition.

Off-Balance Sheet Arrangements

None

CRITICAL ACCOUNTING POLICIES

An appreciation of our critical accounting policies is necessary to understand our financial results. These policies may require management to make difficult and subjective judgments regarding uncertainties, and as a result, such estimates may significantly impact our financial results. The precision of these estimates and the likelihood of future changes depend on a number of underlying variables and a range of possible outcomes. Our critical accounting policies do not involve the choice between alternative methods of accounting. We have applied our critical accounting policies and estimation methods consistently.

Principles of Consolidation

The unaudited interim consolidated financial statements include the accounts of Triton Emission Solutions Inc. and our wholly-owned subsidiary, Ecolutions, Inc. On consolidation, we eliminate all significant intercompany balances and transactions.

Foreign Exchange Risk

We are subject to foreign exchange risk on some purchases which are denominated in Canadian dollars. Foreign currency risk arises from the fluctuation of foreign exchange rates and the degree of volatility of these rates relative to the U.S. dollar.  Foreign exchange rate fluctuations may adversely impact our results of operations as exchange rate fluctuations on transactions denominated in currencies other than our functional currency result in gains and losses that are reflected in our Statement of Operations. To the extent the U.S. dollar weakens against foreign currencies, the translation of these foreign currency-denominated transactions will result in increased net revenue. Conversely, our net revenue will decrease when the U.S. dollar strengthens against foreign currencies. We do not believe that we have any material risk due to foreign currency exchange.

Stock Options and other Stock-based Compensation

For equity awards, such as stock options, total compensation cost is based on the grant date fair value and for liability awards, such as stock appreciation rights, total compensation cost is based on the settlement value. We recognize the stock-based compensation expense for all awards over the service period required to earn the award, which is the shorter of the vesting period or the time period an employee becomes eligible to retain the award at retirement.

Fair Value of Financial Instruments

Our financial instruments include cash, accounts receivable, accounts payable, notes and advances payable, amounts due to related parties, loans payable and derivative liabilities. The fair values of these financial instruments approximate their carrying values due to their short maturities.

6

Concentration of Credit Risk

Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash.

At March 31, 2020, we had $2,389 in cash on deposit with a large chartered Canadian bank. As part of our cash management process, we perform periodic evaluations of the relative credit standing of these financial institutions. We have not experienced any losses in cash balances and do not believe we are exposed to any significant credit risk on our cash.

Reclassifications

Certain prior period amounts in the accompanying unaudited interim condensed consolidated financial statements have been reclassified to conform to the current period’s presentation. These reclassifications had no effect on the consolidated results of operations or financial position for any period presented.

Recent Accounting Standards and Pronouncements

Recent accounting pronouncements issued by the Financial Accounting Standards Board or other authoritative standards groups with future effective dates are either not applicable or are not expected to be significant to our financial statements.

Not Applicable.

In connection with the preparation of this Quarterly Report on Form 10-Q, an evaluation was carried out by our management, with the participation of our Chief Financial Officer and Chairman of our board of directors, of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (“Exchange Act”) as of March 31, 2020. Based on the evaluation, our management concluded, as of the end of the period covered by this report, that our disclosure controls and procedures were not effective in recording, processing, summarizing, and reporting information required to be disclosed, within the time periods specified in the Securities and Exchange Commission’s rules and forms due to limited segregation of duties and critical shortage of funding.

Due to financial constraints, the management decided not to engage services of an independent accountant to review its quarterly consolidated financial statements. To the management’s best knowledge the financial statements included in this Form 10-Q have been prepared in accordance with US GAAP and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X; they include all adjustments considered necessary for a fair presentation of the results of operations and financial position and all such adjustments are of a normal recurring nature.

During the quarter ended March 31, 2020, other than noted above, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

7

None.

We incorporate by reference the Risk Factors included as Item 1A of our Annual Report on Form 10-K we filed with the Securities and Exchange Commission on March 30, 2020.

None.

None.

Not applicable.

None

The following exhibits are either provided with this Quarterly Report or are incorporated herein by reference:

8

9

(1)Filed as an exhibit to our Registration statement on Form SB-2 filed on August 2, 2001. 

(2)Filed as an exhibit to our Quarterly Report on Form 10-QSB filed on April 15, 2003. 

(3)Filed as an exhibit to our Current Report on Form 8-K filed on July 13, 2012. 

(4)Filed as an exhibit to our Current Report on Form 8-K filed on August 27, 2014. 

(5)Filed as an exhibit to our Current Report on Form 8-K filed on November 14, 2005. 

(6)Filed as an exhibit to our Current Report on Form 8-K filed on December 11, 2012. 

(7)Filed as an exhibit to our Current Report on Form 8-K filed on January 17, 2013. 

(8)Filed as an exhibit to our Current Report on Form 8-K filed on February 6, 2013. 

(9)Filed as an exhibit to our Current Report on Form 8-K filed on July 24, 2013. 

(10)Filed as an exhibit to our Current Report on Form 8-K filed on August 22, 2013. 

(11)Filed as an exhibit to our Current Report on Form 8-K filed on January 3, 2014. 

(12)Filed as an exhibit to our Current Report on Form 8-K filed on January 17, 2014. 

(13)Filed as an exhibit to our Current Report on Form 8-K filed on February 18, 2014. 

(14)Filed as an exhibit to our Current Report on Form 8-K filed on March 3, 2014. 

(15)Filed as an exhibit to our Current Report on Form 8-K filed on March 11, 2014. 

(16)Filed as an exhibit to our Current Report on Form 8-K filed on April 17, 2014. 

(17)Filed as an exhibit to our Current Report on Form 8-K filed on August 1, 2014. 

(18)Filed as an exhibit to our Current Report on Form 8-K filed on September 9, 2014. 

(19)Filed as an exhibit to our Current Report on Form 8-K filed on September 12, 2014. 

(20)Filed as an exhibit to our Current Report on Form 8-K filed on January 26, 2015. 

(21)Filed as an exhibit to our Current Report on Form 8-K filed on March 12, 2015. 

(22)Filed as an exhibit to our Current Report on Form 8-K filed on August 3, 2015. 

(23)Filed as an exhibit to our Current Report on Form 8-K filed on September 4, 2015. 

(24)Filed as an exhibit to our Current Report on Form 8-K filed on September 10, 2015. 

(25)Filed as an exhibit to our Annual Report on Form 10-K filed on April 14, 2016 

(26)Filed as an exhibit to our Current Report on Form 8-K filed on November 12, 2015. 

(27)Filed as an exhibit to our Current Report on Form 8-K filed on December 23, 2015. 

(28)Filed as an exhibit to our Current Report on Form 8-K filed on February 1, 2016. 

(29)Filed as an exhibit to our Current Report on Form 10-Q filed on November 21, 2016. 

(30)Filed as an exhibit to our Annual Report on Form 10-K filed on April 14, 2017. 

(31)Filed as an exhibit to our Annual Report on Form 10-Q filed on November 14, 2018. 

10

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

11